Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Renal Failure

  Free Subscription


Articles published in J Am Soc Nephrol

Retrieve available abstracts of 122 articles:
HTML format



Single Articles


    June 2022
  1. SILBERZWEIG J, Bhat JG, Dittrich M, Durvasula R, et al
    Collaboration between Dialysis Providers and the American Society of Nephrology: Dialysis in the COVID Pandemic.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2021111475. doi: 10.1681/ASN.2021111475.
    PubMed    


  2. SEHGAL A, Slutzman J, Huml A
    Sources of Variation in the Carbon Footprint of Hemodialysis Treatment.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010086. doi: 10.1681/ASN.2022010086.
    PubMed     Abstract available


  3. YUN HR, Joo YS, Kim HW, Park JT, et al
    Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Jun 2. pii: ASN.2022010080. doi: 10.1681/ASN.2022010080.
    PubMed     Abstract available


  4. QUINN RR, Lam NN, Ravani P, Oliver MJ, et al
    The Advancing American Kidney Health Initiative: The Challenge of Measuring Success.
    J Am Soc Nephrol. 2022;33:1060-1062.
    PubMed    


    May 2022
  5. GRITTER M, Wouda R, Yeung S, Wieers M, et al
    Effects of Short-Term Potassium Chloride Supplementation in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 May 24. pii: ASN.2022020147. doi: 10.1681/ASN.2022020147.
    PubMed     Abstract available


  6. PEREZ L, Biruete A
    Lack of Cultural and Language Concordant Nutrition Education for Hispanic/Latinx Individuals with Chronic Kidney Disease: A Call to Action.
    J Am Soc Nephrol. 2022 May 11. pii: ASN.2022040430. doi: 10.1681/ASN.2022040430.
    PubMed    


  7. OKA Y, Miyazaki M, Takatsu S, Matsuda H, et al
    Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030248. doi: 10.1681/ASN.2022030248.
    PubMed    


  8. PFAU A, Knauf F
    Authors' Reply: Calcium-Based Phosphate Binders and Plasma Oxalate Concentration in Dialysis Patients.
    J Am Soc Nephrol. 2022 May 2. pii: ASN.2022030359. doi: 10.1681/ASN.2022030359.
    PubMed    


    April 2022
  9. RIZZOLO K, Cervantes L, Shen J
    Racial and Ethnic Disparities in Home Dialysis Use in the United States: Barriers and Solutions.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022030288. doi: 10.1681/ASN.2022030288.
    PubMed    


  10. PROVENZANO M, Puchades M, Garofalo C, Jongs N, et al
    Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial.
    J Am Soc Nephrol. 2022 Apr 19. pii: ASN.2022020207. doi: 10.1681/ASN.2022020207.
    PubMed     Abstract available


  11. FISHBANE S, Pollock CA, El-Shahawy M, Escudero ET, et al
    Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
    J Am Soc Nephrol. 2022;33:850-866.
    PubMed     Abstract available


  12. LOCATELLI F, Del Vecchio L
    The Search for the Perfect Agent for Anemia Management in Chronic Kidney Disease.
    J Am Soc Nephrol. 2022;33:662-664.
    PubMed    


    March 2022
  13. SHANKAR S, Beckett J, Tipton T, Ogbe A, et al
    SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients.
    J Am Soc Nephrol. 2022 Mar 31. pii: ASN.2021121587. doi: 10.1681/ASN.2021121587.
    PubMed    


  14. BEETHAM KS, Coombes JS, Howden EJ
    Authors' Reply: More Research is Still Needed to Support the Real-World Generalizability of the Benefits of Lifestyle Interventions for Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 30. pii: ASN.2022030244. doi: 10.1681/ASN.2022030244.
    PubMed    


  15. BAERMAN EA, Kaplan J, Shen JI, Winkelmayer WC, et al
    Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
    J Am Soc Nephrol. 2022 Mar 21. pii: ASN.2021060854. doi: 10.1681/ASN.2021060854.
    PubMed     Abstract available


  16. VERISSIMO T, Faivre A, Rinaldi A, Lindenmeyer M, et al
    Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Mar 10. pii: ASN.2021050680. doi: 10.1681/ASN.2021050680.
    PubMed     Abstract available


  17. OLIVER MJ, Thomas D, Balamchi S, Ip J, et al
    Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada.
    J Am Soc Nephrol. 2022 Mar 9. pii: ASN.2021091262. doi: 10.1681/ASN.2021091262.
    PubMed     Abstract available


  18. XU C, Smith E, Tiong M, Ruderman I, et al
    Interventions to Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
    J Am Soc Nephrol. 2022 Mar 1. pii: ASN.2021101327. doi: 10.1681/ASN.2021101327.
    PubMed     Abstract available


    February 2022
  19. VLASSCHAERT C, McNaughton A, Chong M, Cook E, et al
    Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease.
    J Am Soc Nephrol. 2022 Feb 23. pii: ASN.2021060774. doi: 10.1681/ASN.2021060774.
    PubMed     Abstract available


  20. SAEED F, Moss A, Duberstein P, Fiscella K, et al
    Enabling Patient Choice: The "Deciding Not to Decide" Option for Older Adults Facing Dialysis Decisions.
    J Am Soc Nephrol. 2022 Feb 15. pii: ASN.2021081143. doi: 10.1681/ASN.2021081143.
    PubMed    


  21. BUNDY JD, Rahman M, Matsushita K, Jaeger BC, et al
    Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    J Am Soc Nephrol. 2022 Feb 10. pii: ASN.2021060747. doi: 10.1681/ASN.2021060747.
    PubMed     Abstract available


  22. BRUNELLI S, Sibbel S, Karpinski S, Marlowe G, et al
    Comparative Effectiveness of mRNA-Based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2.S Vaccine for Prevention of COVID-19 among Dialysis Patients.
    J Am Soc Nephrol. 2022 Feb 8. pii: ASN.2021101395. doi: 10.1681/ASN.2021101395.
    PubMed     Abstract available


  23. JACOBS L, Devresse A, Baudoux T, Collart F, et al
    Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2022;33:455.
    PubMed    


    January 2022
  24. LEE AM, Hu J, Xu Y, Abraham AG, et al
    Using Machine Learning to Identify Metabolomic Signatures of Pediatric Chronic Kidney Disease Etiology.
    J Am Soc Nephrol. 2022 Jan 11. pii: ASN.2021040538. doi: 10.1681/ASN.2021040538.
    PubMed     Abstract available


    December 2021
  25. GUO X, Xu L, Velazquez H, Chen TM, et al
    Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021040439. doi: 10.1681/ASN.2021040439.
    PubMed     Abstract available


  26. BANSAL N, Zelnick L, Reynolds K, Harrison T, et al
    Management of Adults with Newly Diagnosed Atrial Fibrillation With and Without Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Dec 17. pii: ASN.2021060744. doi: 10.1681/ASN.2021060744.
    PubMed     Abstract available


  27. FUKUMA S, Sasaki S, Taguri M, Goto R, et al
    Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens.
    J Am Soc Nephrol. 2021 Dec 13. pii: ASN.2021050664. doi: 10.1681/ASN.2021050664.
    PubMed     Abstract available


  28. BEETHAM K, Krishnasamy R, Stanton T, Sacre J, et al
    Effect of a 3-Year Lifestyle Intervention in Patients with Chronic Kidney Disease: A Randomized Clinical Trial.
    J Am Soc Nephrol. 2021 Dec 10. pii: ASN.2021050668. doi: 10.1681/ASN.2021050668.
    PubMed     Abstract available


    November 2021
  29. SIBBEL S, McKeon K, Luo J, Wendt K, et al
    Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 Vaccines in Patients on Hemodialysis.
    J Am Soc Nephrol. 2021 Nov 17. pii: ASN.2021060778. doi: 10.1681/ASN.2021060778.
    PubMed     Abstract available


  30. THIEME CJ, Blazquez-Navarro A, Safi L, Kaliszczyk S, et al
    Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
    J Am Soc Nephrol. 2021;32:2725-2727.
    PubMed    


  31. GILL JS, Schold J, Kaplan B
    Understanding Risks and Our Responsibility to Living Donors.
    J Am Soc Nephrol. 2021;32:2691-2693.
    PubMed    


    October 2021
  32. RUHL A, Jeffries N, Yang Y, Naik R, et al
    Alpha Globin Gene Copy Number is Associated with Prevalent Chronic Kidney Disease and Incident End-stage Kidney Disease among Black Americans.
    J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050653. doi: 10.1681/ASN.2021050653.
    PubMed     Abstract available


  33. BUDDE K, Prashar R, Haller H, Rial M, et al
    Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.
    J Am Soc Nephrol. 2021 Oct 27. pii: ASN.2021050628. doi: 10.1681/ASN.2021050628.
    PubMed     Abstract available


  34. HORIMOTO A, Xue D, Cai J, Lash J, et al
    Genome-Wide Admixture Mapping of Estimated Glomerular Filtration Rate and Chronic Kidney Disease Identify European and African Ancestry-of-Origin Loci in Hispanic and Latino Individuals in the United States.
    J Am Soc Nephrol. 2021 Oct 20. pii: ASN.2021050617. doi: 10.1681/ASN.2021050617.
    PubMed     Abstract available


  35. GARCIA P, Anand S, Han J, Montez-Rath M, et al
    COVID19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021070936. doi: 10.1681/ASN.2021070936.
    PubMed    


  36. LIOUFAS N, Pascoe E, Hawley C, Elder G, et al
    Systematic Review and Meta-analyses of Effects of Phosphate-lowering Agents in Non-dialysis Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Oct 13. pii: ASN.2021040554. doi: 10.1681/ASN.2021040554.
    PubMed     Abstract available


  37. NIU J, Saeed MK, Winkelmayer WC, Erickson KF, et al
    Patient Health Outcomes following Dialysis Facility Closures in the United States.
    J Am Soc Nephrol. 2021;32:2613-2621.
    PubMed     Abstract available


  38. DANZIGER J, Mukamal KJ, Weinhandl E
    Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD.
    J Am Soc Nephrol. 2021;32:2425-2434.
    PubMed     Abstract available


    September 2021
  39. VAN PRAET J, Reynders M, De Bacquer D, Viaene L, et al
    Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.
    J Am Soc Nephrol. 2021 Sep 29. pii: ASN.2021070908. doi: 10.1681/ASN.2021070908.
    PubMed     Abstract available


  40. NIGRA AE, Navas-Acien A
    Racial Inequalities in Drinking Water Lead Exposure: A Wake-Up Call to Protect Patients with End Stage Kidney Disease.
    J Am Soc Nephrol. 2021 Sep 20. pii: ASN.2021060793. doi: 10.1681/ASN.2021060793.
    PubMed    


  41. WETMORE J, Johansen K, Liu J, Peng Y, et al
    Changes in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.
    J Am Soc Nephrol. 2021 Sep 17. pii: ASN.2021040579. doi: 10.1681/ASN.2021040579.
    PubMed     Abstract available


  42. WEI S
    Long-Term Outcomes of Children Undergoing Dialysis-treated AKI: Some Opinions and Prospects.
    J Am Soc Nephrol. 2021 Sep 16. pii: ASN.2021060862. doi: 10.1681/ASN.2021060862.
    PubMed    


  43. IDROVO A, Pignatelli R, Loar R, Nieuwsma A, et al
    Preserved Cerebral Oxygenation with Worsening Global Myocardial Strain during Pediatric Chronic Hemodialysis.
    J Am Soc Nephrol. 2021 Sep 13. pii: ASN.2021020193. doi: 10.1681/ASN.2021020193.
    PubMed     Abstract available


  44. CUKOR D, Zelnick L, Charytan D, Shallcross A, et al
    Patient Activation Measure in Dialysis Dependent Patients in the United States.
    J Am Soc Nephrol. 2021 Sep 1. pii: ASN.2021030315. doi: 10.1681/ASN.2021030315.
    PubMed    


  45. MEYER TW, Blanco IJ, Grimm JC, Leypoldt JK, et al
    Barriers to Reducing Hemodialysis Time and Frequency in Patients with Residual Kidney Function.
    J Am Soc Nephrol. 2021;32:2112-2116.
    PubMed    


  46. GO AS, Tan TC, Chertow GM, Ordonez JD, et al
    Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study.
    J Am Soc Nephrol. 2021;32:2303-2314.
    PubMed     Abstract available


  47. BOUDHABHAY I, Delestre F, Coutance G, Gnemmi V, et al
    Reappraisal of Renal Arteritis in ANCA-associated Vasculitis: Clinical Characteristics, Pathology, and Outcome.
    J Am Soc Nephrol. 2021;32:2362-2374.
    PubMed     Abstract available


    August 2021
  48. HEHER E, Elias N
    Addressing Transplant Candidacy When Evaluating Safety of Direct Oral Anticoagulant Agents in Patients on Hemodialysis.
    J Am Soc Nephrol. 2021 Aug 18. pii: ASN.2021060814. doi: 10.1681/ASN.2021060814.
    PubMed    


  49. TUMMALAPALLI SL, Anderson G
    Comparative Health Care Spending for Dialysis: An Example of Public Cost Containment?
    J Am Soc Nephrol. 2021 Aug 16. pii: ASN.2021050694. doi: 10.1681/ASN.2021050694.
    PubMed     Abstract available


  50. POCKROS BM, Finch DJ, Weiner DE
    Dialysis and Total Health Care Costs in the United States and Worldwide: The Financial Impact of a Single-Payer Dominant System in the US.
    J Am Soc Nephrol. 2021 Aug 6. pii: ASN.2021010082. doi: 10.1681/ASN.2021010082.
    PubMed    


  51. LACSON E, Argyropoulos C, Manley H, Aweh G, et al
    Immunogenicity of SARS-CoV-2 Vaccine in Dialysis.
    J Am Soc Nephrol. 2021 Aug 4. pii: ASN.2021040432. doi: 10.1681/ASN.2021040432.
    PubMed     Abstract available


  52. BANHAM GD, Godlee A, Faustini SE, Cunningham AF, et al
    Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.
    J Am Soc Nephrol. 2021 Aug 2. pii: ASN.2021020188. doi: 10.1681/ASN.2021020188.
    PubMed    


  53. WANG X, Grobe N, Patel A, Sharma S, et al
    Presence of SARS-CoV-2 Antibodies in Spent Peritoneal Dialysate.
    J Am Soc Nephrol. 2021;32:1865-1867.
    PubMed    


  54. KRITMETAPAK K, Kumar R
    Novel Insights into Mechanisms of Intestinal Phosphate Absorption in Patients with Chronic Kidney Disease.
    J Am Soc Nephrol. 2021;32:1830-1832.
    PubMed    


  55. SHEN CR, Jia XY, Luo W, Olaru F, et al
    Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.
    J Am Soc Nephrol. 2021;32:1887-1897.
    PubMed     Abstract available


    July 2021
  56. KREDIET R
    Acquired Decline in Ultrafiltration in Peritoneal Dialysis: The Role of Glucose.
    J Am Soc Nephrol. 2021 Jul 28. pii: ASN.2021010080. doi: 10.1681/ASN.2021010080.
    PubMed     Abstract available


  57. WANG X, Grobe N, Haq Z, Thwin O, et al
    Testing of Worn Face Masks for Timely Diagnosis of SARS-CoV-2 in Hemodialysis Patients.
    J Am Soc Nephrol. 2021 Jul 19. pii: ASN.2021060812. doi: 10.1681/ASN.2021060812.
    PubMed     Abstract available


  58. PFAU A, Ermer T, Coca S, Tio M, et al
    High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.
    J Am Soc Nephrol. 2021 Jul 19. pii: ASN.2020121793. doi: 10.1681/ASN.2020121793.
    PubMed     Abstract available


  59. CHERTOW G, Vart P, Jongs N, Toto R, et al
    Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Jul 16. pii: ASN.2021020167. doi: 10.1681/ASN.2021020167.
    PubMed     Abstract available


  60. MYCHALECKYJ J, Valo E, Ichimura T, Ahluwalia T, et al
    Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.
    J Am Soc Nephrol. 2021 Jul 14. pii: ASN.2020101457. doi: 10.1681/ASN.2020101457.
    PubMed     Abstract available


  61. MADILL-THOMSEN K, Boehmig G, Bromberg J, Einecke G, et al
    Donor-Specific Antibody is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified As No Rejection.
    J Am Soc Nephrol. 2021 Jul 12. pii: ASN.2021040433. doi: 10.1681/ASN.2021040433.
    PubMed     Abstract available


  62. TAYLOR K, Crews D
    Toward Antiracist Reimbursement Policy in End-Stage Kidney Disease: From Equality to Equity.
    J Am Soc Nephrol. 2021 Jul 12. pii: ASN.2021020189. doi: 10.1681/ASN.2021020189.
    PubMed    


  63. COHEN D, Sibbel S, Marlowe G, Bludorn K, et al
    Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.
    J Am Soc Nephrol. 2021 Jul 2. pii: ASN.2021030387. doi: 10.1681/ASN.2021030387.
    PubMed     Abstract available


    June 2021
  64. KOTSIS F, Schultheiss U, Wuttke M, Schlosser P, et al
    Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021010063. doi: 10.1681/ASN.2021010063.
    PubMed     Abstract available


  65. WU S
    Correction: Long-term exposure to ambient PM2.5 and increased risk of chronic kidney disease prevalence in China.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021050692. doi: 10.1681/ASN.2021050692.
    PubMed     Abstract available


  66. SATAKE E, Saulnier PJ, Kobayashi H, Gupta M, et al
    Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of End Stage Kidney Disease in Diabetes.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2021010105. doi: 10.1681/ASN.2021010105.
    PubMed     Abstract available


  67. JAIN N, Corken A, Kumar A, Davis C, et al
    Role of Platelets in Chronic Kidney Disease.
    J Am Soc Nephrol. 2021 Jun 17. pii: ASN.2020121806. doi: 10.1681/ASN.2020121806.
    PubMed     Abstract available


  68. DANTHU C, Hantz S, Dahlem A, Duval M, et al
    Humoral Response after SARS-Cov-2 mRNA Vaccine in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    J Am Soc Nephrol. 2021 Jun 16. pii: ASN.2021040490. doi: 10.1681/ASN.2021040490.
    PubMed     Abstract available


  69. ANAND S, Montez-Rath M, Han J, Garcia P, et al
    Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
    J Am Soc Nephrol. 2021 Jun 11. pii: ASN.2021050611. doi: 10.1681/ASN.2021050611.
    PubMed    


  70. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.
    J Am Soc Nephrol. 2021 Jun 10. pii: ASN.2021040480. doi: 10.1681/ASN.2021040480.
    PubMed     Abstract available


  71. HSU CM, Weiner DE, Aweh G, Salenger P, et al
    Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients.
    J Am Soc Nephrol. 2021 Jun 9. pii: ASN.2020111653. doi: 10.1681/ASN.2020111653.
    PubMed    


  72. TUMMALAPALLI SL, Silberzweig J, Cukor D, Lin J, et al
    Racial and Neighborhood-level Disparities in COVID-19 Incidence Among Patients on Hemodialysis in New York City.
    J Am Soc Nephrol. 2021 Jun 3. pii: ASN.2020111606. doi: 10.1681/ASN.2020111606.
    PubMed     Abstract available


  73. WEINHANDL ED, Wetmore JB, Peng Y, Liu J, et al
    Initial Effects of COVID-19 on Patients with ESKD.
    J Am Soc Nephrol. 2021;32:1444-1453.
    PubMed     Abstract available


  74. MAYRDORFER M, Liefeldt L, Wu K, Rudolph B, et al
    Exploring the Complexity of Death-Censored Kidney Allograft Failure.
    J Am Soc Nephrol. 2021;32:1513-1526.
    PubMed     Abstract available


  75. LADIN K, Neckermann I, D'Arcangelo N, Koch-Weser S, et al
    Advance Care Planning in Older Adults with CKD: Patient, Care Partner, and Clinician Perspectives.
    J Am Soc Nephrol. 2021;32:1527-1535.
    PubMed     Abstract available


    May 2021
  76. GRENON E, Canet E
    High Incidence of Circuit Clotting in Critically-ill COVID-19 Patients Treated With Renal Replacement Therapy.
    J Am Soc Nephrol. 2021 May 28. pii: ASN.2021040528. doi: 10.1681/ASN.2021040528.
    PubMed    


  77. ROBINSON C, Jeyakumar N, Luo B, Wald R, et al
    Long-term Kidney Outcomes Following Childhood Acute Kidney Injury Receiving Dialysis: A Population-based Cohort Study.
    J Am Soc Nephrol. 2021 May 26. pii: ASN.2020111665. doi: 10.1681/ASN.2020111665.
    PubMed     Abstract available


  78. RAMSPEK CL, Evans M, Wanner C, Drechsler C, et al
    Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.
    J Am Soc Nephrol. 2021;32:1174-1186.
    PubMed     Abstract available


    April 2021
  79. GARCIA P, Montez-Rath ME, Moore H, Flotte J, et al
    SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey.
    J Am Soc Nephrol. 2021 Apr 29. pii: ASN.2021010104. doi: 10.1681/ASN.2021010104.
    PubMed     Abstract available


  80. TANGRI N, Garg AX, Ferguson TW, Dixon S, et al
    Effects of a Knowledge-Translation Intervention on Early Dialysis Initiation: A Cluster Randomized Trial.
    J Am Soc Nephrol. 2021 Apr 15. pii: ASN.2020091254. doi: 10.1681/ASN.2020091254.
    PubMed     Abstract available


    March 2021
  81. PERGOLA PE, Rosenbaum DP, Yang Y, Chertow GM, et al
    A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
    J Am Soc Nephrol. 2021 Mar 25. pii: ASN.2020101398. doi: 10.1681/ASN.2020101398.
    PubMed     Abstract available


  82. DE VRIESE AS, Caluwe R, Van Der Meersch H, De Boeck K, et al
    Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.
    J Am Soc Nephrol. 2021 Mar 22. pii: ASN.2020111566. doi: 10.1681/ASN.2020111566.
    PubMed     Abstract available


  83. CHERIF A, Willetts JL, Usvyat L, Wang Y, et al
    Comparative Analysis of SARS-CoV-2 Reproduction Rates in the Dialysis and General Populations.
    J Am Soc Nephrol. 2021 Mar 8. pii: ASN.2020121691. doi: 10.1681/ASN.2020121691.
    PubMed    


  84. LIU F, Wang J, Ye Q, Fu H, et al
    Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?
    J Am Soc Nephrol. 2021 Mar 1. pii: ASN.2020111664. doi: 10.1681/ASN.2020111664.
    PubMed    


  85. KU E, McCulloch CE, Adey DB, Li L, et al
    Racial Disparities in Eligibility for Preemptive Waitlisting for Kidney Transplantation and Modification of eGFR Thresholds to Equalize Waitlist Time.
    J Am Soc Nephrol. 2021;32:677-685.
    PubMed     Abstract available


  86. RAVINDRAN A, Casal Moura M, Fervenza FC, Nasr SH, et al
    In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
    J Am Soc Nephrol. 2021;32:695-706.
    PubMed     Abstract available


    February 2021
  87. SAKHI H, Dahmane D, Attias P, Kofman T, et al
    Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    J Am Soc Nephrol. 2021 Feb 26. pii: ASN.2020111618. doi: 10.1681/ASN.2020111618.
    PubMed     Abstract available


  88. KLIGER AS, Silberzweig J
    COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021.
    J Am Soc Nephrol. 2021 Feb 26. pii: ASN.2020121766. doi: 10.1681/ASN.2020121766.
    PubMed    


  89. FISHBANE S, El-Shahawy MA, Pecoits-Filho R, Van BP, et al
    Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.
    J Am Soc Nephrol. 2021 Feb 10. pii: ASN.2020081150. doi: 10.1681/ASN.2020081150.
    PubMed     Abstract available


  90. ISAKA Y, Hamano T, Fujii H, Tsujimoto Y, et al
    Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients.
    J Am Soc Nephrol. 2021 Feb 5. pii: ASN.2020050598. doi: 10.1681/ASN.2020050598.
    PubMed     Abstract available


  91. SUMIDA K, Dashputre AA, Potukuchi PK, Thomas F, et al
    Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis.
    J Am Soc Nephrol. 2021 Feb 5. pii: ASN.2020081120. doi: 10.1681/ASN.2020081120.
    PubMed     Abstract available


  92. CANNEY M, Barbour SJ, Zheng Y, Coppo R, et al
    Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy.
    J Am Soc Nephrol. 2021;32:436-447.
    PubMed     Abstract available


  93. AHLENSTIEL-GRUNOW T, Liu X, Schild R, Oh J, et al
    Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial.
    J Am Soc Nephrol. 2021;32:502-516.
    PubMed     Abstract available


  94. CALDERON-MARGALIT R, Pleniceanu O, Tzur D, Stern-Zimmer M, et al
    Childhood Cancer and the Risk of ESKD.
    J Am Soc Nephrol. 2021;32:495-501.
    PubMed     Abstract available


  95. REHNBERG J, Symreng A, Ludvigsson JF, Emilsson L, et al
    Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    J Am Soc Nephrol. 2021;32:411-423.
    PubMed     Abstract available


    January 2021
  96. ZHENG Z, Waikar SS, Schmidt IM, Landis JR, et al
    Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2021 Jan 18. pii: ASN.2020030239. doi: 10.1681/ASN.2020030239.
    PubMed     Abstract available


  97. HSU S, Zelnick LR, Lin YS, Best CM, et al
    Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.
    J Am Soc Nephrol. 2021;32:188-198.
    PubMed     Abstract available


  98. KELLY JT, Su G, Zhang, Qin X, et al
    Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis.
    J Am Soc Nephrol. 2021;32:239-253.
    PubMed     Abstract available


    December 2020
  99. REDDY YNV, Tummalapalli SL, Mendu ML
    Ensuring the Equitable Advancement of American Kidney Health-the Need to Account for Socioeconomic Disparities in the ESRD Treatment Choices Model.
    J Am Soc Nephrol. 2020 Dec 30. pii: ASN.2020101466. doi: 10.1681/ASN.2020101466.
    PubMed    


  100. PERGOLA PE, Devalaraja M, Fishbane S, Chonchol M, et al
    Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
    J Am Soc Nephrol. 2020 Dec 3. pii: ASN.2020050595. doi: 10.1681/ASN.2020050595.
    PubMed     Abstract available


  101. PALZER EF, Vempati S, Helgeson ES, Matas AJ, et al
    Long-Term Living Kidney Donor Risk: A Web-Based Calculator.
    J Am Soc Nephrol. 2020;31:2968-2969.
    PubMed    


    November 2020
  102. CASAL MOURA M, Irazabal MV, Eirin A, Zand L, et al
    Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    J Am Soc Nephrol. 2020;31:2688-2704.
    PubMed     Abstract available


  103. O'HARE AM, Butler CR, Taylor JS, Wong SPY, et al
    Thematic Analysis of Hospice Mentions in the Health Records of Veterans with Advanced Kidney Disease.
    J Am Soc Nephrol. 2020;31:2667-2677.
    PubMed     Abstract available


    October 2020
  104. SCHRAUBEN SJ, Shou H, Zhang X, Anderson AH, et al
    Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Oct 29. pii: ASN.2020040487. doi: 10.1681/ASN.2020040487.
    PubMed     Abstract available


  105. CHAZOT G, Lemoine S, Kocevar G, Kalbacher E, et al
    Intracellular Phosphate and ATP Depletion Measured by Magnetic Resonance Spectroscopy in Patients Receiving Maintenance Hemodialysis.
    J Am Soc Nephrol. 2020 Oct 22. pii: ASN.2020050716. doi: 10.1681/ASN.2020050716.
    PubMed     Abstract available


  106. WEISS S, Bhat P, Del Pilar Fernandez M, Bhat JG, et al
    COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island.
    J Am Soc Nephrol. 2020 Oct 19. pii: ASN.2020070932. doi: 10.1681/ASN.2020070932.
    PubMed    


  107. GUPTA S, Coca SG, Chan L, Melamed ML, et al
    AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
    J Am Soc Nephrol. 2020 Oct 16. pii: ASN.2020060897. doi: 10.1681/ASN.2020060897.
    PubMed     Abstract available


  108. LEPPING RJ, Montgomery RN, Sharma P, Mahnken JD, et al
    Normalization of Cerebral Blood Flow, Neurochemicals, and White Matter Integrity after Kidney Transplantation.
    J Am Soc Nephrol. 2020 Oct 16. pii: ASN.2020050584. doi: 10.1681/ASN.2020050584.
    PubMed     Abstract available


  109. KING KL, Husain SA, Schold JD, Patzer RE, et al
    Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients.
    J Am Soc Nephrol. 2020 Oct 9. pii: ASN.2020030335. doi: 10.1681/ASN.2020030335.
    PubMed     Abstract available


  110. COFFMAN TM, Chan CM, Choong LH, Curran I, et al
    Perspectives on COVID-19 from Singapore: Impact on ESKD Care and Medical Education.
    J Am Soc Nephrol. 2020;31:2242-2245.
    PubMed    


  111. DANZIGER J, Angel Armengol de la Hoz M, Celi LA, Cohen RA, et al
    Use of Do-Not-Resuscitate Orders for Critically Ill Patients with ESKD.
    J Am Soc Nephrol. 2020;31:2393-2399.
    PubMed     Abstract available


  112. OSHIMA M, Neal B, Toyama T, Ohkuma T, et al
    Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program.
    J Am Soc Nephrol. 2020;31:2446-2456.
    PubMed     Abstract available


    September 2020
  113. RODRIGUEZ-ESPINOSA D, Broseta JJ, Cuadrado E, Maduell F, et al
    Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
    J Am Soc Nephrol. 2020 Sep 29. pii: ASN.2020081193. doi: 10.1681/ASN.2020081193.
    PubMed    


  114. RAHMAN M, Wang X, Bundy JD, Charleston J, et al
    Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    J Am Soc Nephrol. 2020 Sep 24. pii: ASN.2020030236. doi: 10.1681/ASN.2020030236.
    PubMed     Abstract available


  115. KHAIRALLAH P, Kudose S, Morris HK, Ratner LE, et al
    Reversal of Donor Hepatitis C Virus-Related Mesangial Proliferative GN in a Kidney Transplant Recipient.
    J Am Soc Nephrol. 2020 Sep 16. pii: ASN.2020060820. doi: 10.1681/ASN.2020060820.
    PubMed    


  116. BUTLER CR, Reese PP, Perkins JD, Hall YN, et al
    End-of-Life Care among US Adults with ESKD in the United States Who Were Waitlisted or Received a Kidney Transplant, 2005-2014.
    J Am Soc Nephrol. 2020 Sep 9. pii: ASN.2020030342. doi: 10.1681/ASN.2020030342.
    PubMed     Abstract available


  117. RAYEGO-MATEOS S, Morgado-Pascual JL, Valdivielso JM, Sanz AB, et al
    TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.
    J Am Soc Nephrol. 2020;31:2026-2042.
    PubMed     Abstract available


    August 2020
  118. ELIAS M, Pievani D, Randoux C, Louis K, et al
    COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes.
    J Am Soc Nephrol. 2020 Aug 26. pii: ASN.2020050639. doi: 10.1681/ASN.2020050639.
    PubMed     Abstract available


    July 2020
  119. LOUIS K, Macedo C, Bailly E, Lau L, et al
    Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation.
    J Am Soc Nephrol. 2020 Jul 28. pii: ASN.2020030320. doi: 10.1681/ASN.2020030320.
    PubMed     Abstract available


    May 2020
  120. COYNE DW, Fishbane S
    The Value of Intravenous Iron: Beyond the Cave of Speculation.
    J Am Soc Nephrol. 2020;31:896-897.
    PubMed    


    March 2020
  121. JACQUEMONT L, Tilly G, Yap M, Doan-Ngoc TM, et al
    Terminally Differentiated Effector Memory CD8(+) T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure.
    J Am Soc Nephrol. 2020 Mar 12. pii: ASN.2019080847. doi: 10.1681/ASN.2019080847.
    PubMed     Abstract available


  122. MENDU ML, Tummalapalli SL, Lentine KL, Erickson KF, et al
    Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.
    J Am Soc Nephrol. 2020;31:602-614.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: